794 related articles for article (PubMed ID: 26844283)
1. Modulation of Autoimmune T-Cell Memory by Stem Cell Educator Therapy: Phase 1/2 Clinical Trial.
Delgado E; Perez-Basterrechea M; Suarez-Alvarez B; Zhou H; Revuelta EM; Garcia-Gala JM; Perez S; Alvarez-Viejo M; Menendez E; Lopez-Larrea C; Tang R; Zhu Z; Hu W; Moss T; Guindi E; Otero J; Zhao Y
EBioMedicine; 2015 Dec; 2(12):2024-36. PubMed ID: 26844283
[TBL] [Abstract][Full Text] [Related]
2. Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells.
Zhao Y; Jiang Z; Zhao T; Ye M; Hu C; Yin Z; Li H; Zhang Y; Diao Y; Li Y; Chen Y; Sun X; Fisk MB; Skidgel R; Holterman M; Prabhakar B; Mazzone T
BMC Med; 2012 Jan; 10():3. PubMed ID: 22233865
[TBL] [Abstract][Full Text] [Related]
3. Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial.
Zhao Y; Jiang Z; Zhao T; Ye M; Hu C; Zhou H; Yin Z; Chen Y; Zhang Y; Wang S; Shen J; Thaker H; Jain S; Li Y; Diao Y; Chen Y; Sun X; Fisk MB; Li H
BMC Med; 2013 Jul; 11():160. PubMed ID: 23837842
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.
Jalili RB; Zhang Y; Hosseini-Tabatabaei A; Kilani RT; Khosravi Maharlooei M; Li Y; Salimi Elizei S; Warnock GL; Ghahary A
PLoS One; 2016; 11(1):e0146970. PubMed ID: 26765526
[TBL] [Abstract][Full Text] [Related]
5. Stem cell educator therapy and induction of immune balance.
Zhao Y
Curr Diab Rep; 2012 Oct; 12(5):517-23. PubMed ID: 22833322
[TBL] [Abstract][Full Text] [Related]
6. Hair regrowth in alopecia areata patients following Stem Cell Educator therapy.
Li Y; Yan B; Wang H; Li H; Li Q; Zhao D; Chen Y; Zhang Y; Li W; Zhang J; Wang S; Shen J; Li Y; Guindi E; Zhao Y
BMC Med; 2015 Apr; 13():87. PubMed ID: 25896390
[TBL] [Abstract][Full Text] [Related]
7. Stem Cell Educator therapy in type 1 diabetes: From the bench to clinical trials.
Zhao Y; Knight CM; Jiang Z; Delgado E; Van Hoven AM; Ghanny S; Zhou Z; Zhou H; Yu H; Hu W; Li H; Li X; Perez-Basterrechea M; Zhao L; Zhao Y; Giangola J; Weinberg R; Mazzone T
Autoimmun Rev; 2022 May; 21(5):103058. PubMed ID: 35108619
[TBL] [Abstract][Full Text] [Related]
8. New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetes.
Zhao Y; Lin B; Dingeldein M; Guo C; Hwang D; Holterman MJ
Transl Res; 2010 May; 155(5):211-6. PubMed ID: 20403575
[TBL] [Abstract][Full Text] [Related]
9. β-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice.
Manzoor F; Johnson MC; Li C; Samulski RJ; Wang B; Tisch R
Eur J Immunol; 2017 Jan; 47(1):144-154. PubMed ID: 27859048
[TBL] [Abstract][Full Text] [Related]
10. Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis.
Abdulahad WH; van der Geld YM; Stegeman CA; Kallenberg CG
Kidney Int; 2006 Sep; 70(5):938-47. PubMed ID: 16837919
[TBL] [Abstract][Full Text] [Related]
11. Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice.
Amatya C; Radichev IA; Ellefson J; Williams M; Savinov AY
Mol Ther; 2018 Jan; 26(1):184-198. PubMed ID: 28988715
[TBL] [Abstract][Full Text] [Related]
12. Toward cell-based therapy of type I diabetes.
Kabelitz D; Geissler EK; Soria B; Schroeder IS; Fändrich F; Chatenoud L
Trends Immunol; 2008 Feb; 29(2):68-74. PubMed ID: 18182324
[TBL] [Abstract][Full Text] [Related]
13. Platelet-Derived Mitochondria Display Embryonic Stem Cell Markers and Improve Pancreatic Islet β-cell Function in Humans.
Zhao Y; Jiang Z; Delgado E; Li H; Zhou H; Hu W; Perez-Basterrechea M; Janostakova A; Tan Q; Wang J; Mao M; Yin Z; Zhang Y; Li Y; Li Q; Zhou J; Li Y; Martinez Revuelta E; Maria García-Gala J; Wang H; Perez-Lopez S; Alvarez-Viejo M; Menendez E; Moss T; Guindi E; Otero J
Stem Cells Transl Med; 2017 Aug; 6(8):1684-1697. PubMed ID: 28685960
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic islet autoimmunity.
Boitard C
Presse Med; 2012 Dec; 41(12 P 2):e636-50. PubMed ID: 23182678
[TBL] [Abstract][Full Text] [Related]
15. Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4+ T cells infiltrate islets in type 1 diabetes.
Pathiraja V; Kuehlich JP; Campbell PD; Krishnamurthy B; Loudovaris T; Coates PT; Brodnicki TC; O'Connell PJ; Kedzierska K; Rodda C; Bergman P; Hill E; Purcell AW; Dudek NL; Thomas HE; Kay TW; Mannering SI
Diabetes; 2015 Jan; 64(1):172-82. PubMed ID: 25157096
[TBL] [Abstract][Full Text] [Related]
16. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
[TBL] [Abstract][Full Text] [Related]
17. Immature Dendritic Cell Therapy Confers Durable Immune Modulation in an Antigen-Dependent and Antigen-Independent Manner in Nonobese Diabetic Mice.
Lo J; Xia CQ; Peng R; Clare-Salzler MJ
J Immunol Res; 2018; 2018():5463879. PubMed ID: 29651443
[TBL] [Abstract][Full Text] [Related]
18. Cellular mechanisms of CCL22-mediated attenuation of autoimmune diabetes.
Bischoff L; Alvarez S; Dai DL; Soukhatcheva G; Orban PC; Verchere CB
J Immunol; 2015 Apr; 194(7):3054-64. PubMed ID: 25740943
[TBL] [Abstract][Full Text] [Related]
19. Obstacles and opportunities for targeting the effector T cell response in type 1 diabetes.
Buckner JH; Nepom GT
J Autoimmun; 2016 Jul; 71():44-50. PubMed ID: 26948997
[TBL] [Abstract][Full Text] [Related]
20. α
Cheung KW; Wu T; Ho SF; Wong YC; Liu L; Wang H; Chen Z
J Virol; 2018 Apr; 92(8):. PubMed ID: 29386290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
